Search results
Institutions own 21% of LianBio (NASDAQ:LIAN) shares but private equity firms control 54% of the...
Simply Wall St. via Yahoo Finance· 11 months agoKey Insights Significant control over LianBio by private equity firms implies that the general...
LianBio (LIAN) Up After Pfizer Opts in Rights to RSV Drug in China
Zacks via Yahoo Finance· 1 year agoAs a result of Pfizer's (PFE) opt-in for LianBio's (LIAN) rights to develop RSV therapeutic...
All You Need to Know About LianBio Sponsored ADR (LIAN) Rating Upgrade to Strong Buy
Zacks via Yahoo Finance· 7 months agoLianBio Sponsored ADR (LIAN) might move higher on growing optimism about its earnings prospects,...
Why LianBio Stock Is Shooting Through the Roof This Week
Motley Fool· 8 months agoLianBio (NASDAQ: LIAN) stock is skyrocketing this week. LianBio published a press release on Oct. 24...
LianBio (NASDAQ:LIAN) Is In A Good Position To Deliver On Growth Plans
Simply Wall St. via Yahoo Finance· 1 year agoJust because a business does not make any money, does not mean that the stock will go down. For...
LianBio to shut down, return cash to investors
BioPharma Dive via Yahoo Finance· 4 months agoThe biotech is planning to dissolve less than four years after launching with plans to license drugs and market them in China and other Asian countries.
LianBio To Shut BridgeBio-Partnered Bile Duct Cancer Drug Trial
Benzinga via Yahoo Finance· 2 years agoLianBio (NASDAQ: LIAN) reported that its partner BridgeBio Pharma Inc (NASDAQ: BBIO) informed...
Why LianBio Stock Is Skyrocketing Today
Motley Fool· 8 months agoThe huge gain came after the company announced that it entered into an agreement to hand over exclusive rights to market cardiomyopathy drug mavacamten...
We're Not Very Worried About LianBio's (NASDAQ:LIAN) Cash Burn Rate
Simply Wall St. via Yahoo Finance· 9 months agoThere's no doubt that money can be made by owning shares of unprofitable businesses. For example,...
LianBio Touts Positive Data From Bristol Myers-Partnered Heart Drug In Chinese Patients
Benzinga via Yahoo Finance· 1 year agoLianBio (NASDAQ: LIAN) announced topline results from the Phase 3 EXPLORER-CN trial investigating...
